miRagen Therapeutics

Miragen Therapeutics is a clinical-stage biopharmaceutical company discovering and developing proprietary RNA-targeted therapeutics with a specific focus on microRNAs and their role in diseases. microRNAs are short RNA molecules, or oligonucleotides, that regulate gene expression and play vital roles in influencing the pathways responsible for several disease processes. The company has advanced two product candidates, cobomarsen, also known as MRG-106, and MRG-201, into clinical development. The company is also developing MRG-110 under a license and collaboration agreement with Les Laboratoires Servier and Institut de Recherches Servier.
  • TickerMGEN
  • ISINUS60463E1038
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for MGEN

ValuEngine Rating and Forecast Report for MGEN

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for MGEN

ValuEngine Rating and Forecast Report for MGEN

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for MGEN

ValuEngine Rating and Forecast Report for MGEN

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Liana Moussatos ...
  • Shveta Dighe

ATS: Promising Preclinical Data for Next Gen miR-29 Mimic to Treat IPF

ValuEngine Rating and Forecast Report for MGEN

ValuEngine Rating and Forecast Report for MGEN

ValuEngine Rating and Forecast Report for MGEN

ValuEngine Rating and Forecast Report for MGEN

ValuEngine Rating and Forecast Report for MGEN

ValuEngine Rating and Forecast Report for MGEN

ValuEngine Rating and Forecast Report for MGEN

ValuEngine Rating and Forecast Report for MGEN

ValuEngine Rating and Forecast Report for MGEN

ValuEngine Rating and Forecast Report for MGEN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch